George Cusatis
Impact in
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
Papers in
- Oncology 6
- Drug Transport and Resistance Mechanisms 3
- Pancreatic and Hepatic Oncology Research 2
- Cancer Cells and Metastasis 1
- CAR-T cell therapy research 1
-
- Renal Transplantation Outcomes and Treatments 1
- Co-authors
- Alex Sparreboom (4 shared papers)Manuel M. Hidalgo (6 shared papers)Sharyn D. Baker (3 shared papers)Susan E. Bates (2 shared papers)Roxann Ingersoll (2 shared papers)Jaap Verweij (2 shared papers)Julie Renee Brahmer (1 shared paper)Robert W. Robey (1 shared paper)
- Journals
- Clinical Cancer Research (2 papers)Pediatric Blood & Cancer (1 paper)Cancer Research (1 paper)JNCI Journal of the National Cancer Institute (1 paper)Pharmacogenomics (1 paper)
- Partner nations
- United StatesNetherlandsItaly
In The Last Decade
George Cusatis
9 papers receiving 907 citations
Peers
Comparison fields: 5 of 72
- Oncology 635
- Pharmacology 90
- Cancer Research 130
- Biotechnology 66
- Pediatrics, Perinatology and Child Health 97
Countries citing papers authored by George Cusatis
This map shows the geographic impact of George Cusatis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Cusatis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Cusatis more than expected).
Fields of papers citing papers by George Cusatis
This network shows the impact of papers produced by George Cusatis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Cusatis. The network helps show where George Cusatis may publish in the future.
Co-authors
The 25 scholars most cited alongside George Cusatis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 372 | |
| 2 | 2006 | 204 | |
| 3 | 2007 | 161 | |
| 4 | 2005 | 62 | |
| 5 | 2008 | 62 | |
| 6 | 2012 | 45 | |
| 7 | 2007 | 22 | |
| 8 | 2006 | 12 | |
| 9 | In vivo testing of Mycophenolic acid (MPA) in primary pancreatic cancer (PaCa) xenografts | 2007 | 1 |
About George Cusatis
George Cusatis is a scholar working on Oncology, Transplantation, Molecular Biology, Pharmacology and Cancer Research, having authored 9 papers that have together received 941 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (3 papers), Pancreatic and Hepatic Oncology Research (2 papers), Cancer therapeutics and mechanisms (2 papers), Cancer Genomics and Diagnostics (1 paper), 14-3-3 protein interactions (1 paper), Cancer Cells and Metastasis (1 paper), CAR-T cell therapy research (1 paper) and Renal Transplantation Outcomes and Treatments (1 paper). The work is most often cited by research in Oncology (635 citations), Pharmacology (90 citations), Cancer Research (130 citations), Biotechnology (66 citations) and Pediatrics, Perinatology and Child Health (97 citations). George Cusatis has collaborated with scholars based in United States, Netherlands and Italy. Frequent co-authors include Alex Sparreboom, Manuel M. Hidalgo, Sharyn D. Baker, Susan E. Bates, Roxann Ingersoll, Jaap Verweij, Julie Renee Brahmer, Robert W. Robey, Jing Li and Vanesa Gregorc. Their work appears in journals such as Clinical Cancer Research, Pediatric Blood & Cancer, Cancer Research, JNCI Journal of the National Cancer Institute and Pharmacogenomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.